BIOMAT Database Logo BIOMAT Database Logo

Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulphate proteoglycan 4. 2018

Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.

CD antigens are well known as therapeutic targets of B-cell lymphoma. To isolate therapeutic antibodies that recognize novel targets other than CD antigens, we constructed a phage display combinatorial antibody Fab library from bone marrow lymphocytes of B-cell lymphoma patient. To eliminate antibodies reactive with known B-cell lymphoma antigen, non-hematopoietic and patient's sera reactive HeLaS3 cells was selected as a target of whole cell panning. Five rounds of panning against live HeLaS3 cells retrieved single Fab clone, termed AHSA (Antibody to HeLa Surface Antigen). Using phage display random peptide library, LSYLEP was identified as an epitope sequence of AHSA. LC-MS/MS analysis of AHSA-precipitated HeLaS3 cell lysates detected several fragments corresponding to the sequence of chondroitin sulphate proteoglycan 4 (CSPG4) core protein. Since LSYLEP sequence was at the position of 313-318 of CSPG4, we considered that CSPG4 was AHSA-associated antigen. Double staining of CSPG4-postive MDA-MB-435S cells with AHSA and anti-CSPG4 rabbit antibody showed identical staining position, and reduced AHSA reactivity was observed in CSPG4-siRNA treated MDA-MB-435S cells. In conclusion, we retrieved a human Fab from antibody library of B-cell lymphoma patient, and identified CSPG4 as a recognizing antigen. AHSA may have potential benefits for development of CSPG4-targeting theranostics for B-cell lymphoma.

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D011508 Chondroitin Sulfate Proteoglycans Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains. Proteochondroitin Sulfates,Chondroitin Sulfate Proteoglycan,Proteochondroitin Sulfate,Proteoglycan, Chondroitin Sulfate,Proteoglycans, Chondroitin Sulfate,Sulfate Proteoglycan, Chondroitin,Sulfate Proteoglycans, Chondroitin
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016393 Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Cell Lymphoma,B Cell Lymphoma,B-Cell Lymphomas,Lymphoma, B Cell,Lymphomas, B-Cell

Related Publications

Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Recombinant human monoclonal Fab fragments against rotavirus from phage display combinatorial libraries.
January 1999, Journal of biochemistry,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Cell-free translation of messenger RNA for chondroitin sulphate proteoglycan core protein in rat cartilage.
January 1984, The Biochemical journal,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Recombinant core protein fragment of phosphacan, a brain specific chondroitin sulfate proteoglycan, promote excitotoxic cell death of cultured rat hippocampal neurons.
May 2001, Neuroscience letters,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Nature of the interaction of chondroitin 4-sulphate and chondroitin sulphate-proteoglycan with collagen.
January 1971, The Biochemical journal,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein.
May 1988, The Biochemical journal,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture.
April 1993, Human antibodies and hybridomas,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Characterization of a chondroitin sulphate proteoglycan from ovine brain.
March 1977, Journal of neurochemistry,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.
May 2018, Journal of biochemistry,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
A chondroitin sulphate proteoglycan from human cultured glial cells aggregates with hyaluronic acid.
October 1978, Biochemical and biophysical research communications,
Yoko Egami, and Yuta Narushima, and Motohiro Ohshima, and Akira Yoshida, and Naruki Yoneta, and Yasufumi Masaki, and Kunihiko Itoh
Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma.
February 2011, Blood,
Copied contents to your clipboard!